Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.

Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.

[Anonymous].  2017.  Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.. American heart journal. 188:87-92.

Sacubitril/valsartan in PARADIGM-HF.

Prognostic Significance of Discharge Hyponatremia in Heart Failure Patients With Normal Admission Sodium (from the ESCAPE Trial).

Still sour about lactic acidosis years later: role of metformin in heart failure.

Admission-to-discharge temperature reduction in decompensated heart failure is associated with rehospitalization.

Temporary Mechanical Circulatory Support for Cardiogenic Shock.

Extent of jugular venous distension and lower extremity edema are the best tools from history and physical examination to identify heart failure exacerbation.

Extent of jugular venous distension and lower extremity edema are the best tools from history and physical examination to identify heart failure exacerbation.

[Anonymous].  2017.  Extent of jugular venous distension and lower extremity edema are the best tools from history and physical examination to identify heart failure exacerbation.. Herz.

Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes.

Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes.

[Anonymous].  2017.  Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes.. Scientific reports. 7(1):14829.

A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support.

A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support.

[Anonymous].  2018.  A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support.. Resuscitation. 122:1-5.

Successful Liver Transplantation From a Donor With a Continuous-Flow Left Ventricular Assist Device for 9 Months.